Italia - italiano - myHealthbox

guna - roe extract, acido glicirretico , vitamina e , provitamina d , boswellia serrata, lecitina - crema - aqua, octyldodecanol, cetearyl alcohol, glycerin, alcohol denat., ceteareth-20, glycyrrhetinic acid, zanthoxylum alatum extraxt, roe extract, hydrogenated lecithin, boswellia serrata gum, 7-dehydrocholesterol, oleyl alcohol , glucose, dimethicone, xanthan - cosmetici - creme

Unione Europea - italiano - EMA (European Medicines Agency)

novartis europharm limited - ruxolitinib (come fosfato) - myeloproliferative disorders; polycythemia vera; graft vs host disease - agenti antineoplastici - myelofibrosis (mf)jakavi is indicated for the treatment of disease related splenomegaly or symptoms in adult patients with primary myelofibrosis (also known as chronic idiopathic myelofibrosis), post polycythaemia vera myelofibrosis or post essential thrombocythaemia myelofibrosis. policitemia vera (pv)jakavi è indicato per il trattamento di pazienti adulti affetti da policitemia vera, che sono resistenti o intolleranti di hydroxyurea. graft versus host disease (gvhd)jakavi is indicated for the treatment of patients aged 12 years and older with acute graft versus host disease or chronic graft versus host disease who have inadequate response to corticosteroids or other systemic therapies (see section 5.

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - ruxolitinibum - compresse - ruxolitinibum 5 mg ut ruxolitinibi phosphas, lactosum monohydricum 71.45 mg, cellulosum microcristallinum, carboxymethylamylum natricum a, hydroxypropylcellulosum, povidonum k 30, silica colloidalis anhydrica, magnesii stearas, pro compresso corresp. natrium 0.32 mg. - myelofibrose, polycythaemia vera, akute graft-versus-host-krankheit - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - ruxolitinibum - compresse - ruxolitinibum 15 mg ut ruxolitinibi phosphas, lactosum monohydricum 214.35 mg, cellulosum microcristallinum, carboxymethylamylum natricum a, hydroxypropylcellulosum, povidonum k 30, silica colloidalis anhydrica, magnesii stearas, pro compresso corresp. natrium 0.97 mg. - myelofibrose, polycythaemia vera, akute graft-versus-host-krankheit - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - ruxolitinibum - compresse - ruxolitinibum 20 mg ut ruxolitinibi phosphas, lactosum monohydricum 285.8 mg, cellulosum microcristallinum, carboxymethylamylum natricum a, hydroxypropylcellulosum, povidonum k 30, silica colloidalis anhydrica, magnesii stearas, pro compresso corresp. natrium 1.29 mg. - myelofibrose, polycythaemia vera, akute graft-versus-host-krankheit - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - ruxolitinibum - compresse - ruxolitinibum 10 mg ut ruxolitinibi phosphas, lactosum monohydricum 142.9 mg, cellulosum microcristallinum, carboxymethylamylum natricum a, hydroxypropylcellulosum, povidonum k 30, silica colloidalis anhydrica, magnesii stearas, pro compresso corresp. natrium 0.65 mg. - myelofibrose, polycythaemia vera, akute graft-versus-host-krankheit - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

ebi-pharm ag - okoubaka aubrevillei e cortice d2 - gocce per uso orale - okoubaka aubrevillei e cortice d2 corrisp. ethanolum 70 % v/v. - gemäss homöopathischem arzneimittelbild bei gastroenteritiden nach lebensmittelvergiftungen - farmaci omeopatici

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

piam farmaceutici s.p.a. - rosuvastatina e acido acetilsalicilico - rosuvastatina e acido acetilsalicilico

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

ebi-pharm ag - argenti nitras d12, bryonia cretica spag. peka d6, echinacea spag. peka d6, glechoma hederacea spag. peka d6, hydrastis canadensis extract canadensis (ph. eur.hom.) d12, magnesio fluoratum (hab) d12, okoubaka aubrevillei e cortice d4, pulsatilla pratensis spag. peka d6 - gocce per uso orale - argenti nitras d12 75 mg, bryonia cretica spag. peka d6 145 mg echinacea spag. peka d6 165 mg, glechoma hederacea spag. peka d6 155 mg, hydrastis canadensis extract canadensis (ph. eur.hom.) d12 75 mg, magnesio fluoratum (hab) d12 75 mg, okoubaka aubrevillei e cortice d4 165 mg, pulsatilla pratensis spag. peka d6 145 mg annuncio solutionem pro 1 g, corrisp. ethanolum 18 % v/v. - gemäss homöopathischem arzneimittelbild bei schleimhautentzündungen im bereich des magen-darmtraktes - farmaci omeopatici

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

herbamed ag - apis mellifica d4, luffa operculata (hab) d4, okoubaka aubrevillei e cortice d4, thryallis glauca (hab) d3 - omeopatici heuschnupfentropfen - apis mellifica d4, luffa operculata (hab) d4, okoubaka aubrevillei e cortice d4, thryallis glauca d3 ana partes ad solutionem, corresp. ethanolum 58 % v/v. - secondo homöopathischem arzneimittelbild in caso di rinite allergica a pollini, febbre da fieno, con bruciore agli occhi e gonfiore del naso e membrane dell'occhio - farmaci omeopatici